Calliditas
Calliditas: Additional details and data from competitor (Redeye)
2019-01-17 15:59
Omeros, a competitor to Calliditas, announced today that their Phase III design has been amended following a meeting with the FDA. Further, the company presented additional data from their Phase II study.
info@redeye.se (Redeye.se)
Redeye AB - Redeye.se